Related Experiment Videos
Immunological characterization of factor VIII inhibitors by a sensitive micro-ELISA method
J M Sánchez-Cuenca1, E Carmona, M J Villanueva
1Research Center, La Fe Hospital, Valencia, Spain.
Thrombosis Research
|March 15, 1990
Summary
A new micro-ELISA method accurately characterizes factor VIII (F. VIII) inhibitors. This technique identifies inhibitor Ig class, light chain type, and IgG subclasses, aiding hemophilia and SLE patient management.
Area of Science:
- Immunology
- Hematology
Background:
- Factor VIII (F. VIII) inhibitors pose a significant challenge in managing hemophilia and certain autoimmune diseases.
- Accurate immunological characterization of these inhibitors is crucial for effective treatment strategies.
Purpose of the Study:
- To describe a novel micro-ELISA method for the detailed immunological characterization of F. VIII inhibitors.
- To assess the utility of this method in differentiating inhibitor types in patients.
Main Methods:
- Utilized microplates sensitized with anti-von Willebrand factor (vWF) IgG.
- Employed peroxidase-conjugated antisera for Ig class and light chain determination.
- Used alkaline phosphatase-conjugated monoclonal antibodies to analyze IgG subclasses.
Main Results:
- Characterized F. VIII inhibitors from 9 patients (8 hemophilia, 1 SLE).
- All inhibitors were primarily IgG class, with one also showing IgA.
- Eight inhibitors were polyclonal; 7 were solely IgG4 subclass, while 2 included all four IgG subclasses.
Conclusions:
- The developed micro-ELISA is a simple, accurate, and highly sensitive method for F. VIII inhibitor characterization.
- This technique can detect inhibitors as low as 0.156 Bethesda Units/ml.
- Provides valuable insights into inhibitor profiles for improved patient care.